HUP9903230A2 - Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same - Google Patents

Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same

Info

Publication number
HUP9903230A2
HUP9903230A2 HU9903230A HUP9903230A HUP9903230A2 HU P9903230 A2 HUP9903230 A2 HU P9903230A2 HU 9903230 A HU9903230 A HU 9903230A HU P9903230 A HUP9903230 A HU P9903230A HU P9903230 A2 HUP9903230 A2 HU P9903230A2
Authority
HU
Hungary
Prior art keywords
diclofenac
gamma
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU9903230A
Other languages
Hungarian (hu)
Inventor
Wilfried Fischer
Anna Sendl-Lang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9600758A external-priority patent/HUP9600758A2/en
Application filed filed Critical
Priority to HU9903230A priority Critical patent/HUP9903230A3/en
Publication of HUP9903230A2 publication Critical patent/HUP9903230A2/en
Publication of HUP9903230A3 publication Critical patent/HUP9903230A3/en

Links

Abstract

Composition (I) comprising \- 50 wt.% of an inclusion compound formed from diclofenac and ~c-cyclodextrin in a molar ratio of 1:2 is new. PREFERRED COMPOSITIONS - (I) may contain 50 wt.% by of the 1:2 drug/cyclodextrin complex with the remainder being a 1:1 complex. Additionally (I) may contain \- 80 (preferably 95)% of the 1:2 complex. Diclofenac is preferably present as the Na salt. Formulations are preferably dry solids provided as granulates, tablets or effervescent tablets.
HU9903230A 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same HUP9903230A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9903230A HUP9903230A3 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9600758A HUP9600758A2 (en) 1996-03-27 1996-03-27 Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
HU9903230A HUP9903230A3 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
HUP9903230A2 true HUP9903230A2 (en) 2000-07-28
HUP9903230A3 HUP9903230A3 (en) 2000-09-28

Family

ID=89999430

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903230A HUP9903230A3 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same

Country Status (1)

Country Link
HU (1) HUP9903230A3 (en)

Also Published As

Publication number Publication date
HUP9903230A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
CA2271302A1 (en) Dentifrice compositions containing polyphosphate and fluoride
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
CA2327723A1 (en) Bicyclic hydroxamic acid derivatives
CA2235655A1 (en) Oral compositions comprising porous calcium carbonate
BG103268A (en) Propionic acid derivatives and their application
IL115790A0 (en) Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof
HUP9903174A2 (en) Pharmaceutical composition comprising coenzyme q10
ME00880B (en) Inclusion complexes of aryl-heterocyclic salts
WO1996017587A3 (en) Oral compositions containing stabilized stannous compounds
CA2271420A1 (en) Dentifrice compositions containing polyphosphate and monofluorophosphate
DK0975235T4 (en) Nutritional Compositions Containing Oligosaccharides
CA2295035A1 (en) Pharmaceutical formulations containing voriconazole
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
AU8452991A (en) 1-aryl-3-pyridinyl-2-propene-1-ones
NZ516290A (en) Substituted phenoxyacetic acids
HK1009139A1 (en) New 6-hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
CA2152771A1 (en) 7-o-ethers of taxane derivatives
CA2137748A1 (en) Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
BR9813602A (en) Pharmaceutical compositions containing micronized bicyclic drugs
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
HUP9801133A3 (en) 1,2,4-triazole-derivatives, fungicide compositions containing these compounds as active ingredients
EP1075796A4 (en) Sweetener compositions
UA42722C2 (en) Sulphides, sulphoxides and sulphones or the pharmaceutically acceptable salts thereof and pharmaceutical composition containing them
HUP9903230A2 (en) Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same